{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:50:03Z","timestamp":1790383803302,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006181","name":"FAPESB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006734","name":"INCT-INOFAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.intimp.2018.09.047","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T07:27:56Z","timestamp":1539070076000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Potent immunosuppressive activity of a phosphodiesterase-4 inhibitor N-acylhydrazone in models of lipopolysaccharide-induced shock and delayed-type hypersensitivity reaction"],"prefix":"10.1016","volume":"65","author":[{"given":"Elisalva Teixeira","family":"Guimar\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Barbosa","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahara Keyse Carvalho","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssio Santana","family":"Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Rodrigo Magalh\u00e3es","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Fernandes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer J.","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Botelho Pereira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.09.047_bb0005","article-title":"Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response","volume":"11","author":"Hung","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2018.09.047_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jcim-2014-0051","article-title":"An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance","volume":"12","author":"Ingawale","year":"2015","journal-title":"J. Complement. Integr. Med."},{"key":"10.1016\/j.intimp.2018.09.047_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/164_2017_26","article-title":"Anti-infective and anti-inflammatory pharmacotherapies","volume":"242","author":"Rosenblatt","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2174\/138955707782331722","article-title":"Privileged structures: a useful concept or the rational design of new lead drugs candidates","volume":"7","author":"Duarte","year":"2007","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bmc.2008.12.045","article-title":"Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates","volume":"17","author":"Tributino","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jmedchem.5b01525","article-title":"Design, synthesis, and pharmacological evaluation of novel N-acylhydrazone derivatives as potent histone deacetylase 6\/8 dual inhibitors","volume":"59","author":"Rodrigues","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0035","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1016\/j.bmcl.2017.10.003","article-title":"Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: design, synthesis and their biological evaluation","volume":"27","author":"Sun","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2018.09.047_bb0040","doi-asserted-by":"crossref","first-page":"85380e","DOI":"10.1371\/journal.pone.0085380","article-title":"Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues","volume":"9","author":"do Amaral","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.09.047_bb0045","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/molecules20023067","article-title":"Novel orally active analgesic and anti-inflammatory cyclohexyl-N-acylhydrazone derivatives","volume":"20","author":"Da Silva","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2018.09.047_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156271","article-title":"Discovery of novel orally active tetrahydro-naphthyl-N-acylhydrazones with in vivo anti-TNF-\u03b1 effect and remarkable anti-inflammatory properties","volume":"11","author":"Cordeiro","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.09.047_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1747-0285.2010.01050.x","article-title":"Synthesis and antiviral evaluation of new N-acylhydrazones containing glycine residue","volume":"77","author":"Tian","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.intimp.2018.09.047_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2012.10.047","article-title":"Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates","volume":"59","author":"Hern\u00e1ndez","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0065","doi-asserted-by":"crossref","first-page":"20374","DOI":"10.3390\/molecules191220374","article-title":"Antiprotozoal activity of (E)-cinnamic N-acylhydrazone derivatives","volume":"19","author":"Carvalho","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2018.09.047_bb0070","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/j.bmc.2016.09.013","article-title":"Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents","volume":"24","author":"Dos Santos Filho","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0075","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1021\/jm300514y","article-title":"Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors","volume":"55","author":"K\u00fcmmerle","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijcard.2014.02.022","article-title":"N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity","volume":"173","author":"Alencar","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0085","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobolograma method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium facilparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2018.09.047_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0092-8674(00)80222-6","article-title":"The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism","volume":"89","author":"Zhong","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2018.09.047_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-1759(81)90094-6","article-title":"A simple and effective method to assess murine delayed type hypersensitivity to proteins","volume":"45","author":"Titus","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2018.09.047_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yjmcc.2015.01.021","article-title":"Cellular and molecular biology of aging endothelial cells","volume":"89 (","author":"Donato","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/157018011796575999","article-title":"Nicotinic acid benzylidene\/phenyl-ethylidene hydrazides: synthesis, antimicrobial evaluation and QSAR studies","volume":"8","author":"Narang","year":"2011","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.intimp.2018.09.047_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cmdc.201500266","article-title":"LASSBio-1829 hydrochloride: development of a new orally active N-acylhydrazone IKK2 inhibitor with anti-inflammatory properties","volume":"11","author":"Guedes","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.intimp.2018.09.047_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cbdd.13085","article-title":"Discovery of naphthyl-N-acylhydrazone p38\u03b1 MAPK inhibitors with in vivoanti-inflammatory and anti-TNF-\u03b1 activity","volume":"91","author":"Freitas","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.intimp.2018.09.047_bb0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejmech.2015.02.041","article-title":"N-(1\u2032-naphthyl)-3, 4, 5-trimethoxybenzohydrazide as microtubule destabilizer: synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia","volume":"96","author":"Salum","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2018.09.047_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0163-7258(96)00016-2","article-title":"The antiglucocorticoid action of mifepristone","volume":"70","author":"Agarwal","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2018.09.047_bb0135","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bph.12308","article-title":"Comparative assessment of PDE 4 and PDE 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis","volume":"170","author":"Gonz\u00e1lez-Garcia","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14740338.2017.1288715","article-title":"Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes","volume":"16","author":"Vedtofte","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.intimp.2018.09.047_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2018.03.019","article-title":"Role of IL-1\u03b2, IL-6 and TNF-\u03b1 cytokines and TNF- \u03b1 promoter variability in Plasmodium vivax infection during pregnancy in endemic population of Jharkhand, India","volume":"97","author":"Singh","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0192-0561(94)90054-X","article-title":"Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor","volume":"16","author":"Prabhakar","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2249.1995.tb03613.x","article-title":"Menius JAJr, Connolly KM. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation","volume":"100","author":"Sekut","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0160","doi-asserted-by":"crossref","first-page":"ra28","DOI":"10.1126\/scisignal.2000202","article-title":"Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105","volume":"2","author":"Wall","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2018.09.047_bb0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: a paradigm for cytokines","volume":"23","author":"Kishimoto","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.intimp.2018.09.047_bb0170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1165\/ajrcmb\/7.4.365","article-title":"Cytokine-cytokine interactions in the context of cytokine networking","volume":"7","author":"Elias","year":"1992","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni938","article-title":"IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages","volume":"4","author":"Yasukawa","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0180","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.15252\/embj.201488856","article-title":"The good, the bad, and the ugly of interleukin-6 signaling","volume":"33","author":"Fuster","year":"2014","journal-title":"EMBO J."},{"issue":"2014","key":"10.1016\/j.intimp.2018.09.047_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ni.2865","article-title":"Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin","volume":"15","author":"Mauer","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0190","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.4049\/jimmunol.160.4.1811","article-title":"The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor","volume":"160","author":"Soares","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0195","doi-asserted-by":"crossref","first-page":"321S","DOI":"10.1378\/chest.112.6_Supplement.321S","article-title":"Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock","volume":"112","author":"Dinarello","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2018.09.047_bb0200","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.4049\/jimmunol.159.12.6253","article-title":"Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram","volume":"159","author":"Ross","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.09.047_bb0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.09.047_bb0210","first-page":"874","article-title":"Antigen specific suppressor cells, receptors, and factors","volume":"7","author":"Dorf","year":"1998","journal-title":"Prog. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918307690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918307690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T20:08:47Z","timestamp":1693944527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918307690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"alternative-id":["S1567576918307690"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.047","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent immunosuppressive activity of a phosphodiesterase-4 inhibitor N-acylhydrazone in models of lipopolysaccharide-induced shock and delayed-type hypersensitivity reaction","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}